Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata often have lower levels of zinc and vitamin D.

Many people diagnosed with androgenic alopecia might actually have hidden scarring or inflammation.

Diphenylcyclopropenone is effective for treating alopecia areata but has a high relapse rate.

The meeting discussed medical findings, including benefits of certain treatments for cancer and heart conditions, and highlighted issues like poor adherence to preventive measures and skill gaps among interns.

A woman's hair loss was initially misdiagnosed as scarring hair loss but was actually a treatable autoimmune hair loss.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

TLR4 is important in aging-related diseases and could be a new treatment target.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Alopecia areata in Taif is common, mainly immune-related, and best treated with topical corticosteroids and vitamins.

High levels of IL6 and CRP, and low levels of vitamin D, might be indicators of alopecia areata.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

The study found that alopecia areata and hypothyroidism increase the risk of each other, but androgenetic alopecia and hypothyroidism do not.

Alopecia areata is a hair loss condition that may be linked to stress and genetics, often requires psychological support, and has no set treatment.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

The text talks about a rare skin condition causing hair loss and suggests that people with this should also check their lung and heart health.

Hypothyroidism may cause certain types of hair loss.

Hormones like testosterone and estrogen significantly affect hair growth and structure.

Using animal names for skin conditions helps with learning and memory.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Non-immune factors play a significant role in alopecia areata.

People with alopecia areata have higher insulin resistance.

Patchy alopecia areata can affect only pigmented hairs, leaving gray hairs untouched.